Suppressors of cytokine signaling (SOCS) proteins in inflammatory bone disorders

被引：12

作者：

Gonzaga Santos, Mariana Rates ^{[1
]}

Queiroz-Junior, Celso M. ^{[2
]}

Moreira Madeira, Mila Fernandes ^{[3
]}

Machado, Fabiana Simao ^{[1
,4
]}

机构：

[1] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil

[2] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil

[3] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil

[4] Univ Fed Minas Gerais, Fac Med, Program Hlth Sci Infect Dis & Trop Med, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil

来源：

BONE | 2020年 / 140卷

关键词：

SOCS; Bone; Inflammation; TUMOR-NECROSIS-FACTOR; OSTEOBLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; CELL RESPONSES; T-CELLS; EXPRESSION; OSTEOCLASTOGENESIS; ARTHRITIS; DISEASE; LIGAND;

D O I：

10.1016/j.bone.2020.115538

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Suppressor of cytokine signaling (SOCS) proteins are significant regulators of cellular immune responses. Therefore, the role of SOCS in bone-inflammatory disorders, including arthritis and periodontitis, has been investigated in experimental and clinical conditions. Recent evidence shows that SOCS proteins are expressed in major bone-related cells, including osteoblasts, osteoclasts, chondrocytes and synoviocytes, although their direct role in these cells is not fully described. These signaling molecules, especially SOCS1, 2 and 3, were shown to play critical roles in the control of bone resorption associated to inflammation. This review focuses on the involvement of SOCS proteins in inflammatory bone remodeling, including their direct and indirect role in the control of osteoclast hyperactivation, during arthritis and periodontitis. The description of the roles of SOCS proteins in inflammatory bone diseases highlights the pathways involved in the pathophysiology of these conditions and, thus, may contribute to the development and improvement of potential therapeutic interventions.

引用

页数：7

共 94 条

[1] Osteoblast differentiation is impaired in SOCS-1-deficient mice [J].

Abe, Tatsuo ;

Nomura, Shintaro ;

Nakagawa, Reiko ;

Fujimoto, Minoru ;

Kawase, Ichiro ;

Naka, Tetsuji .

JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (04) :283-290

[2] A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis [J].

Ahmed, Chulbul M. ;

Massengill, Michael T. ;

Brown, Emily E. ;

Ildefonso, Cristhian J. ;

Johnson, Howard M. ;

Lewin, Alfred S. .

EXPERIMENTAL EYE RESEARCH, 2018, 177 :12-22

[3] SOCS1 mimetics and antagonists: a complementary approach to positive and negative regulation of immune function [J].

Ahmed, Chulbul M. I. ;

Larkin, Joseph, III ;

Johnson, Howard M. .

FRONTIERS IN IMMUNOLOGY, 2015, 6

[4] The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].

Alexander, WS ;

Hilton, DJ .

ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529

[5] BAFF synthesis by rheumatoid synoviocytes is positively controlled by α5β1 integrin stimulation and is negatively regulated by tumor necrosis factor a and toll-like receptor ligands [J].

Alsaleh, Ghada ;

Messer, Laurent ;

Semaan, Noha ;

Boulanger, Nathalie ;

Gottenberg, Jacques-Eric ;

Sibilia, Jean ;

Wachsmann, Dominique .

ARTHRITIS AND RHEUMATISM, 2007, 56 (10) :3202-3214

[6] Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms [J].

Alvarez, Carla ;

Monasterio, Gustavo ;

Cavalla, Franco ;

Cordova, Luis A. ;

Hernandez, Marcela ;

Heymann, Dominique ;

Garlet, Gustavo P. ;

Sorsa, Timo ;

Parnanen, Pirjo ;

Lee, Hsi-Ming ;

Golub, Lorne M. ;

Vernal, Rolando ;

Kantarci, Alpdogan .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[7] Expression of STAT3-regulated genes in circulating CD4+T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis [J].

Anderson, Amy E. ;

Maney, Nicola J. ;

Nair, Nisha ;

Lendrem, Dennis W. ;

Skelton, Andrew J. ;

Diboll, Julie ;

Brown, Philip M. ;

Smith, Graham R. ;

Carmody, Ruaidhri J. ;

Barton, Anne ;

Isaacs, John D. ;

Pratt, Arthur G. .

RHEUMATOLOGY, 2019, 58 (07) :1250-1258

[8] Interleukin-6 deficiency increases inflammatory bone destruction [J].

Balto, K ;

Sasaki, H ;

Stashenko, P .

INFECTION AND IMMUNITY, 2001, 69 (02) :744-750

[9] Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis [J].

Bishop, Ryan T. ;

Marino, Silvia ;

Carrasco, Giovana ;

Li, Boya ;

Allen, Richard J. ;

Sparatore, Anna ;

Ottewell, Penelope D. ;

Mollat, Patrick ;

Sims, Andrew H. ;

Capulli, Mattia ;

Wang, Ning ;

Idris, Aymen I. .

CANCER LETTERS, 2020, 488 :27-39

[10] The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo [J].

Boyle, Kristy ;

Egan, Paul ;

Rakar, Steven ;

Willson, Tracy A. ;

Wicks, Ian P. ;

Metcalf, Donald ;

Hilton, Douglas J. ;

Nicola, Nicos A. ;

Alexander, Warren S. ;

Roberts, Andrew W. ;

Robb, Lorraine .

BLOOD, 2007, 110 (05) :1466-1474

← 1 2 3 4 5 6 7 8 9 10 →